Project title: “Determining the Efficacy of Antimicrobials against MDR Gram-negative Pathogens Following Innate Immunity Sensitization”
Funded: 2024-2026
Jacinda (JAM) Abdul-Mutakabbir PharmD, MPH, AAHIVP. Dr. Abdul-Mutakabbir earned her Bachelors in Sports Medicine from Howard University in 2014 and her PharmD from the University of Saint Joseph School of Pharmacy in 2017. She completed her Postgraduate year 1 (PGY-1) residency at the Howard University Hospital, and then went on to complete an infectious disease pharmacokinetics/ pharmacodynamics research fellowship and Master’s in Public Health at Wayne State University in 2020. She is currently as Assistant Professor of Clinical Pharmacy at the University of California, San Diego in the Skaggs School of Pharmacy and Pharmaceutical Sciences and she joined the program in 2024 working under the tutelage of Victor Nizet, MD and Adriana (Adri) Tremoulet,MD. Her interest includes engaging host innate immunity factors to optimize synergistic antimicrobial combination regimens against multi drug resistant gram-negative pathogens. She also investigates inequities in infectious diseases and antimicrobial resistance and develops tailored interventions to address the uncovered disparities.
Project title: “Characterizing pharmacogenomic contribution to trihexyphenidyl metabolism and creating a precision dosing model for pediatric dystonia”
Funded: 2024
Rose Gelineau-Morel, MD. Dr. Gelineau-Morel completed medical school at Baylor College of Medicine in 2012 and Pediatric Neurology residency at Cincinnati Children’s Hospital in 2017. She joined the faculty at Children’s Mercy Kansas City specializing in pediatric movement disorders, and completed the T32 Pediatric Clinical Pharmacology fellowship in 2024. She is an Assistant Professor at the University of Missouri-Kansas City and was a scholar in the K12 Pediatric Clinical Pharmacology Career Development Program in 2024, working under her primary mentor, Dr. Steven Leeder. Her research focuses on identifying more effective treatments for pediatric dystonia and cerebral palsy.
Project title: “Model- and Biomarker-Informed Anakinra Dosing in Children with Sepsis-Induced MODS”
Funded: 2025
Danielle Green, MD, MS, is an Assistant Professor of Pediatrics at the University of Utah. She earned her medical degree from the University of Washington in 2016 and went on to complete residency training in Pediatrics (2019), followed by fellowships in Pediatric Critical Care Medicine (2022) and Clinical Pharmacology (2023), as well as a Master of Science in Clinical Investigation (2023), all at the University of Utah. Dr. Green’s research focuses on pharmacology in critically ill children, with a particular interest in leveraging pharmacokinetic and pharmacodynamic modeling to develop precision dosing strategies.